The safety of a controversial clot-busting drug has been investigated by researchers.
Researchers have discovered a new factor in the escalation of seizures.
Pembrolizumab produces positive responses that are long-lasting and with fewer side effects than traditional treatments in people with advanced melanoma.
Evidence suggests that bacteria living in the gut may remotely influence the activity of cells in the brain.
The discovery of a naturally occurring process known as RNAi (short for “RNA interference”) has enabled a new platform for drug development that can potentially serve as a basis for the creation of new types of therapeutics.
More than 10 percent of pregnant women develop serious complications during pregnancy. The underlying cause is often a poorly functioning placenta, the organ that nourishes and maintains the fetus.
Phase 3 study met all co-primary and secondary endpoints and achieved statistically significant results.
Umbilical cords of children whose mothers used selective serotonin reuptake inhibitors during pregnancy may be longer than umbilical cords of other newborn children, shows a new study.
More than 4,000 type 2 diabetes patients took part in this placebo-controlled global study over the course of three years.
Electronic cigarettes have sickened rising numbers of young children, a study of U.S. poison center calls has found. Most cases involve swallowing liquid nicotine.
New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults.
The test can be stored at room temperature and read with a simple electronic reader.
The committee is made up of a team of Valeant employees including doctors, scientists and other executives.
The draft guidance recommends the drugs, which are not licensed for everyone who has high cholesterol levels, only if they are provided at the discounted price agreed with the companies.
Patients with the heart rhythm disorder atrial fibrillation (AF) who were treated long term with the blood thinner, warfarin, may have higher rates of dementia, according to a recent study of more than 10,000 patients.